| scholarly article | Q13442814 |
| P2093 | author name string | Lanier LL | |
| Phillips JH | |||
| P2860 | cites work | Analysis by a single cell cytotoxicity assay of natural killer (NK) cells frequencies among human large granular lymphocytes and of the effects of interferon on their activity | Q72665517 |
| A monoclonal antibody against a surface antigen shared by human large granular lymphocytes and granulocytes | Q72673892 | ||
| Augmentation of human natural cell-mediated cytotoxicity by recombinant human interleukin 2 | Q72736387 | ||
| Generation of T cell blasts with NK-like activity in human MLC: cellular precursors, IL 2 responsiveness, and phenotype expression | Q72762913 | ||
| Depletion of human NK cells with monoclonal antibodies allows the generation of cytotoxic T lymphocytes without NK-like cells in mixed cultures | Q72779754 | ||
| Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens | Q72795141 | ||
| Rapidly expanded activated human killer cell clones have strong antitumor cell activity and have the surface phenotype of either T gamma, T-non-gamma, or null cells | Q72815613 | ||
| The Fc receptor for IgG on human natural killer cells: phenotypic, functional, and comparative studies with monoclonal antibodies | Q72815618 | ||
| Requirement for the coexpression of T3 and the T cell antigen receptor on a malignant human T cell line | Q34054993 | ||
| In vitro induction of cytotoxic effector cells with spontaneous killer cell specificity | Q36340447 | ||
| Characteristics of human large granular lymphocytes and relationship to natural killer and K cells | Q36344555 | ||
| Differentiation stages of human natural killer cells in lymphoid tissues from fetal to adult life | Q36347295 | ||
| Characterization of the killer cell generated in the autologous mixed leukocyte reaction | Q36347663 | ||
| Identification of a clonally restricted 90 kD heterodimer on two human cloned natural killer cell lines. Its role in cytotoxic effector function | Q36348129 | ||
| Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity | Q39595504 | ||
| Studies on cytotoxicity generated in human mixed lymphocyte cultures. II. Anti-K562 effectors are distinct from allospecific CTL and can be generated from NK-depleted T cells | Q39890609 | ||
| Distinction of anti-K562 and anti-allocytotoxicity in in vitro-stimulated populations of human lymphocytes | Q39895720 | ||
| Characteristics of human NK clones: target specificity and phenotype | Q41544386 | ||
| Enhanced NK cell activity in mice injected with interferon and interferon inducers | Q41935188 | ||
| Natural killer cells activated in a human mixed lymphocyte response culture identified by expression of Leu-11 and class II histocompatibility antigens | Q41966610 | ||
| Response of resting human peripheral blood natural killer cells to interleukin 2. | Q42153962 | ||
| Sensitization of human lymphocytes against autologous or allogeneic lymphoblastoid cell lines: characteristics of the reactive cells. | Q53721492 | ||
| A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor | Q59068757 | ||
| Evidence for the T3-associated 90K heterodimer as the T-cell antigen receptor | Q59069504 | ||
| Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens | Q69863940 | ||
| Biological Activity of Recombinant Human Interleukin-2 Produced inEscherichia coli | Q70328740 | ||
| Characterization of human granular lymphocyte subpopulations expressing HNK-1 (Leu-7) and Leu-11 antigens in the blood and lymphoid tissues from fetuses, neonates and adults | Q70489174 | ||
| Interleukin 2 dependence of human natural killer (NK) cell activity | Q70984156 | ||
| Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1. | Q71689181 | ||
| Determination of surface antigens on highly purified human NK cells by flow cytometry with monoclonal antibodies | Q72097462 | ||
| Characterization of HNK-1+ (Leu-7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capability | Q72112680 | ||
| Correlation of biophysical properties and cell surface antigenic profile of Percoll gradient-separated human natural killer cells | Q72398923 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lymphocyte | Q715347 |
| P304 | page(s) | 1464-1482 | |
| P577 | publication date | 1985-06-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | A model for the differentiation of human natural killer cells. Studies on the in vitro activation of Leu-11+ granular lymphocytes with a natural killer-sensitive tumor cell, K562 | |
| P478 | volume | 161 |
| Q45077403 | A VEGFR-3 antagonist increases IFN-γ expression on low functioning NK cells in acute myeloid leukemia |
| Q38569499 | Age-related changes in natural killer cell repertoires: impact on NK cell function and immune surveillance |
| Q29619728 | Biology of natural killer cells |
| Q34310907 | CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. |
| Q42041842 | Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis |
| Q69994900 | Effects of systemic in vivo interleukin-2 (IL-2) reconstitution in patients with acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC) on phenotypes and functions of peripheral blood mononuclear cells (PBMC) |
| Q68671543 | Evidence that the reduced number of natural killer cells in type 1 (insulin-dependent) diabetes may be genetically determined |
| Q37408279 | Expansion and activation of natural killer cells for cancer immunotherapy |
| Q37277554 | Expansion of highly cytotoxic human natural killer cells for cancer cell therapy |
| Q69848833 | Flow cytometric and morphologic studies of HNK1+ (Leu 7+) lymphocytes in relation to cytomegalovirus carrier status |
| Q27022458 | Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease |
| Q36351452 | Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express Fc receptors for IgG (CD16/Leu-11 antigen). |
| Q68096908 | Generation of non-MHC restricted killing in cultures stimulated with B cells from chronic lymphocytic leukaemia patients: phenotypic characterization of the precursor and effector cells |
| Q34765436 | Human NK cells proliferate and die in vivo more rapidly than T cells in healthy young and elderly adults |
| Q92546641 | Human peripheral blood DNAM-1neg NK cells are a terminally differentiated subset with limited effector functions |
| Q38171065 | Human thymic and peripheral blood non-MHC-restricted cytotoxic lymphocytes |
| Q69215693 | Induction of lymphokine-activated killer cell against human leukemia cells in vitro |
| Q42939169 | Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen |
| Q37308200 | Killer Immunoglobulin-like Receptors (KIR) haplogroups A and B track with Natural Killer Cells and Cytokine Profile in Aged Subjects: Observations from Octo/Nonagenarians in the Belfast Elderly Longitudinal Free-living Aging STudy (BELFAST). |
| Q33640623 | Lymphocyte subsets in subjects exposed to asbestos: changes in circulating natural killer cells. |
| Q90050594 | NK Cells Contribute to the Immune Risk Profile in Kidney Transplant Candidates |
| Q47570438 | NK cell therapy after hematopoietic stem cell transplantation: can we improve anti-tumor effect? |
| Q92453577 | NK cells for cancer immunotherapy |
| Q45772371 | Nasal natural killer (NK) cell lymphoma: report of a case with activated NK cells containing Epstein-Barr virus and expressing CD21 antigen, and comparative studies of their phenotype and cytotoxicity with normal NK cells |
| Q42039067 | Natural killer cell subsets and natural killer-like T-cell populations in benign and neoplastic B-cell proliferations vary based on clinicopathologic features |
| Q34741864 | Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity |
| Q69098841 | Phenotypic study of CD4+ and CD8+ lymphocyte subsets in relation to cytomegalovirus carrier status and its correlate with pokeweed mitogen-induced B lymphocyte differentiation |
| Q93517466 | Polyclonal proliferation of activated suppressor/cytotoxic T cells with transient depression of natural killer cell function in acute infectious mononucleosis |
| Q67466034 | Preferential accumulation of mature NK cells during human immunosenescence |
| Q37419529 | Replicative potential of human natural killer cells |
| Q36352219 | Requirement for HLA-DR+ accessory cells in natural killing of cytomegalovirus-infected fibroblasts |
| Q40741032 | Selective expansion of human natural killer cells from peripheral blood mononuclear cells by the cell line, HFWT. |
| Q64069915 | Shaping of CD56bri Natural Killer Cells in Patients With Steroid-Refractory/Resistant Acute Graft-vs.-Host Disease via Extracorporeal Photopheresis |
| Q67654237 | The endogenous induction of tumor necrosis factor serum (TNS) for the adjuvant postoperative immunotherapy of cancer —Changes in immunological markers of the blood— |
| Q38184890 | The unconventional expression of IL-15 and its role in NK cell homeostasis |
| Q68096360 | Two-color flow cytometric analysis of monocyte depleted human blood lymphocyte subsets |